When someone seeks therapy, they are often already carrying more than they can comfortably manage. They may be distressed, ...
“It’s hard to get off narcotics because you love them so much—but it’s hard to get off psychiatric drugs because you fear them so much.” Today, he joins us on the Mad In America podcast to talk about ...
The demedicalization and depathologization of care and life are favored by the expansion of collective autonomy and care ...
On January 24, 2023, Lindsay Clancy from Duxbury, Massachusetts took the lives of her three young children, Cora, 5, Dawson, 3, and eight-month-old Callan, and was charged with three counts of ...
I remember he was a very tall man, yet he seemed so small to me at that moment. We were in the nurse’s office, which I couldn’t stand. I’ve never believed fluorescent lights to do anything to calm the ...
Peter Simons was an academic researcher in psychology. Now, as a science writer, he tries to provide the layperson with a view into the sometimes inscrutable world of psychiatric research. As an ...
Sarah White, Chief Executive Officer of Jean Hailes for Women’s Health, is concerned by how many younger women at the organization’s health clinics come in attributing their symptoms to perimenopause, ...
From Mad in Slovenia: Modern positive psychology offers an interesting answer: well-being is not something we achieve once and for all, but something we build every day. Dr. Tal Ben-Shahar developed ...
Depression Drug Approved by FDA Had 11 Failed Trials and an Advisory Committee Vote Against Approval
Editor’s Note: This piece originally appeared on the Mad in America Substack. Two positive studies out of 13 conducted. Rejected by the FDA four times. An FDA advisory committee vote against approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results